Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiannao pills (also known as Jiannao Wan) is a commercially available traditional Chinese medicine (TCM) formulation widely used to nourish the brain, enhance mental acuity, calm the heart, and soothe the spirit. It is prepared from a mixture of 19 medicinal materials, including *Angelicae sinensis radix*, *Bambusae concretio silicea*, *Cistanches herba*, *Ginseng radix et rhizome*, and *Schisandrae chinensis fructus*, with quality control standardized by HPLC measurement of Schisandrol A. Jiannao pills are approved in China for the treatment of memory loss, insomnia, palpitations, and mild cognitive impairment. Preclinical research has also demonstrated its potential therapeutic efficacy in depression and anxiety, with studies suggesting its mechanism of action involves the regulation of the hypothalamic-pituitary-adrenal (HPA) axis, reduction of pro-inflammatory cytokines (such as IL-1β, IL-6, and TNF-α), and modulation of the gut microbiota, potentially mediated via the NF-κB/NLRP3 signaling pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiannao pills.